A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Clinical trial NCT00251459 · COMPLETED
Trial details
- NCT number
- NCT00251459
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Enrollment
- 5000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.